RMC-4998 formic
RMC-4998 formic is an orally active inhibitor targeting the GTP-bound state of the KRASG12C mutant. It forms a trimeric complex with intracellular CYPA and the activated KRASG12C mutant, displaying an IC50 value of 28 nM. This compound inhibits ERK signaling and induces apoptosis in KRASG12C mutant cancer cells and is utilized in tumor research.
Product Specifications
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
032062-HRP 200 µL
ARK5, NT (NUAK1, ARK5, KIAA0537, OMPHK1, NUAK family SNF1-like kinase 1, AMPK-related protein kinase 5, Omphalocele kinase 1) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
VAng-Lsx5008-50gEcoli 50 µg (E. coli)
Recombinant Brucella Abortus rpmC Protein (strain 2308) (aa 1-66)
Sign In for Pricing
View Details RC218327L1 10 µg
Kallikrein 10 (KLK10) (NM_002776) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
MBS6180005-01 0.1 mL
TAZ (tafazzin, BTHS, CMD3A, EFE, EFE2, FLJ27390, G4.5, LVNCX, Taz1, XAP-2) (HRP)
Sign In for Pricing
View Details